glp 1 farmacos NUEVOS FÁRMACOS EN DIABETES MELLITUS Calcium supplement for women and men helps support strong bones and teeth The Rise of GLP-1 Medications

& Glass, D

doi:10.1016/j.clnesp.2020.04.010 Wu L, Xia M, Duan Y, et al

* Treated with insulin glargine

75.4%) compared to the DPP-4i group, although these differences were below the minimum SMD threshold of 0.2

Conventional anti-obesity medications are limited to short-term use and have adverse effects, which have contributed to the rise of GLP-1 RAs, e.g., liraglutide, semaglutide, dulaglutide

[73] [74] Over two years of follow-up, tirzepatide decreased participants' risk of major cardiovascular (CV) complicationsa combined endpoint including urgent heart failure visits, hospitalizations, more frequent diuretic treatment, and CV mortalityby 38% compared to a placebo